
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6779230
[patent_doc_number] => 20030050312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Novel tablets and capsules and a process for its preparation'
[patent_app_type] => new
[patent_app_number] => 10/101456
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3697
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050312.pdf
[firstpage_image] =>[orig_patent_app_number] => 10101456
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/101456 | Novel tablets and capsules and a process for its preparation | Mar 11, 2002 | Abandoned |
Array
(
[id] => 1245162
[patent_doc_number] => 06676961
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-13
[patent_title] => 'Transdermal patch assembly'
[patent_app_type] => B1
[patent_app_number] => 10/092234
[patent_app_country] => US
[patent_app_date] => 2002-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 12
[patent_no_of_words] => 2588
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/676/06676961.pdf
[firstpage_image] =>[orig_patent_app_number] => 10092234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/092234 | Transdermal patch assembly | Mar 5, 2002 | Issued |
Array
(
[id] => 1202140
[patent_doc_number] => 06719994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-13
[patent_title] => 'Inhalatory compositions of Formoterol'
[patent_app_type] => B2
[patent_app_number] => 10/086868
[patent_app_country] => US
[patent_app_date] => 2002-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1344
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/719/06719994.pdf
[firstpage_image] =>[orig_patent_app_number] => 10086868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/086868 | Inhalatory compositions of Formoterol | Mar 3, 2002 | Issued |
Array
(
[id] => 6046941
[patent_doc_number] => 20020168396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Vasodilator impregnated devices and methods'
[patent_app_type] => new
[patent_app_number] => 10/081711
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3228
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168396.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081711
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081711 | Vasodilator impregnated devices and methods | Feb 21, 2002 | Abandoned |
Array
(
[id] => 706877
[patent_doc_number] => 07060288
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'Biomedical devices'
[patent_app_type] => utility
[patent_app_number] => 10/080245
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5096
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060288.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080245
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080245 | Biomedical devices | Feb 20, 2002 | Issued |
Array
(
[id] => 6830419
[patent_doc_number] => 20030181477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 10/082003
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 15428
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181477.pdf
[firstpage_image] =>[orig_patent_app_number] => 10082003
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/082003 | Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor | Feb 20, 2002 | Issued |
Array
(
[id] => 6797579
[patent_doc_number] => 20030176453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 10/080530
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 15450
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176453.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080530 | Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor | Feb 20, 2002 | Issued |
Array
(
[id] => 919459
[patent_doc_number] => 07320803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-22
[patent_title] => 'Crystalline choline ascorbate'
[patent_app_type] => utility
[patent_app_number] => 10/076514
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1830
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/320/07320803.pdf
[firstpage_image] =>[orig_patent_app_number] => 10076514
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/076514 | Crystalline choline ascorbate | Feb 18, 2002 | Issued |
Array
(
[id] => 1136531
[patent_doc_number] => 06780437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-24
[patent_title] => 'Coated potassium chloride granules and tablets'
[patent_app_type] => B2
[patent_app_number] => 10/076892
[patent_app_country] => US
[patent_app_date] => 2002-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4080
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/780/06780437.pdf
[firstpage_image] =>[orig_patent_app_number] => 10076892
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/076892 | Coated potassium chloride granules and tablets | Feb 13, 2002 | Issued |
Array
(
[id] => 6826986
[patent_doc_number] => 20030178044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Micromesh interproximal devices'
[patent_app_type] => new
[patent_app_number] => 10/073682
[patent_app_country] => US
[patent_app_date] => 2002-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11340
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20030178044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10073682
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/073682 | Micromesh interproximal devices | Feb 10, 2002 | Issued |
Array
(
[id] => 6834329
[patent_doc_number] => 20030161874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Controlled release oral dosage form'
[patent_app_type] => new
[patent_app_number] => 10/071257
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6198
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20030161874.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071257
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071257 | Controlled release oral dosage form | Feb 7, 2002 | Issued |
Array
(
[id] => 6649084
[patent_doc_number] => 20030008012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Composition for rectal delivery of an oxazolidinone antibacterial drug'
[patent_app_type] => new
[patent_app_number] => 10/072493
[patent_app_country] => US
[patent_app_date] => 2002-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5856
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20030008012.pdf
[firstpage_image] =>[orig_patent_app_number] => 10072493
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/072493 | Composition for rectal delivery of an oxazolidinone antibacterial drug | Feb 4, 2002 | Abandoned |
Array
(
[id] => 6739796
[patent_doc_number] => 20030157165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Stable saccharide-free tablets comprising a salt of quinapril or moexipril'
[patent_app_type] => new
[patent_app_number] => 10/060191
[patent_app_country] => US
[patent_app_date] => 2002-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2141
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157165.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060191 | Stable saccharide-free tablets comprising a salt of quinapril or moexipril | Jan 31, 2002 | Abandoned |
Array
(
[id] => 6850992
[patent_doc_number] => 20030143195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery'
[patent_app_type] => new
[patent_app_number] => 10/066513
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4669
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10066513
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/066513 | Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery | Jan 29, 2002 | Abandoned |
Array
(
[id] => 6705876
[patent_doc_number] => 20030152610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Cosmetic patch'
[patent_app_type] => new
[patent_app_number] => 10/060060
[patent_app_country] => US
[patent_app_date] => 2002-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16166
[patent_no_of_claims] => 117
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20030152610.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060060
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060060 | Cosmetic patch | Jan 27, 2002 | Abandoned |
Array
(
[id] => 1260501
[patent_doc_number] => 06663888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-16
[patent_title] => 'Pulsatile release histamine H2 antagonist dosage form'
[patent_app_type] => B2
[patent_app_number] => 10/057759
[patent_app_country] => US
[patent_app_date] => 2002-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 4546
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/663/06663888.pdf
[firstpage_image] =>[orig_patent_app_number] => 10057759
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/057759 | Pulsatile release histamine H2 antagonist dosage form | Jan 24, 2002 | Issued |
Array
(
[id] => 7355814
[patent_doc_number] => 20040048902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient'
[patent_app_type] => new
[patent_app_number] => 10/470334
[patent_app_country] => US
[patent_app_date] => 2003-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13387
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048902.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470334
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470334 | Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient | Jan 24, 2002 | Issued |
| 10/031747 | PATCH FORMULATION FOR EXTERNAL USE | Jan 23, 2002 | Abandoned |
| 10/053714 | Fluoridated beverage and composition therefor | Jan 23, 2002 | Abandoned |
Array
(
[id] => 6796467
[patent_doc_number] => 20030175341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Controlled release formulation'
[patent_app_type] => new
[patent_app_number] => 10/054077
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3730
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175341.pdf
[firstpage_image] =>[orig_patent_app_number] => 10054077
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/054077 | Controlled release formulation | Jan 21, 2002 | Issued |